UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

The UCLA Division of Plastic & Reconstructive Surgery

Print
Email
Share

Chia Soo, MD

Chia Soo, MD, FACS
Professor & Vice Chair for Research
Chia Soo, MD

Dr. Soo's research focuses on the regeneration of bone, cartilage, skin, and muscle using novel biologics and stem cells. Her publication record as a clinician-scientist reflects long-standing, multidisciplinary collaborations with scientists from molecular and developmental biology, stem cell biology, and bioengineering. She has a proven track record of successfully assembling and managing multi-investigator projects and has obtained funding from both Federal and non-Federal funding sources including the NIH (RO1s and SBIRs), the Department of Defense, and the State of California through the UC Discovery Grants and the California Institute for Regenerative Medicine (CIRM).  Dr. Soo is currently managing over $8.5 M competitive grant portfolio as the Principal Investigator.

Dr. Soo has extensive industry experience as the founder of Bone Biologics serving as the Executive VP of Business Development. At Bone Biologics she has directly organized and overseen issues relating to animal studies, including design and execution, regulatory affairs on cGMP protein production and Investigation Device Exemption preparation. She has formulated business plans, due diligence reports and was the primary presenter of an initial $6 M fundraising. She was the principal investigator on an NIH SBIR grant while directly managing Bone Biologics patent portfolio with counsel, where she drafted five new and continuing patent applications on NELL-1. She is also the founder of Scarless Laboratories, scientific consultant to the Musculoskeletal Transplant Foundation on the human allograft product FlexTM HD. Dr. Soo currently serves on the Scientific Advisory Board and as a consultant to NellOne Therapeutics and to Histogenics.  Rarely as an academician, Dr. Soo has significant experience in FDA IND related submissions and meetings to move discovery into FDA path. 

Her overall goal is to translate her findings in the laboratory into effective new therapies to prevent and treat debilitating scars, chronic wounds, as well as defects in bone, cartilage, and muscle that will benefit both civilian and military populations.

Recent Publications

 
Contact

Phone: (310) 206-5799
Fax: (310) 206-7579

 

UCLA Rated One of the Top Hospitals in the Nation